Michael Marino

Michael Marino

Net worth: 2 M $ as of 2026-05-30

50 year
Commercial Services
Health Technology
Consumer Services

Profile

Michael Francis Marino currently works at Optinose AS, as Director from 2018 and NewAmsterdam Pharma Co. NV, as Secretary & Chief Legal Officer from 2025.
Mr. Marino also formerly worked at Fibrocell Science, Inc., as Secretary, Senior Vice President & General Counsel from 2015 to 2017, NuPathe, Inc., as Secretary, Senior Vice President & General Counsel from 2013 to 2014, Arthur Andersen LLP, as Auditor, Wilmer Cutler Pickering Hale & Dorr LLP, as Associate, OptiNose, Inc., as Secretary & Chief Legal Officer from 2017 to 2025, Morgan, Lewis & Bockius LLP, as Attorney from 2005 to 2010, and WilmerHale LLP, as Attorney from 2001 to 2005.
Mr. Marino received his undergraduate degree from Villanova University and graduate degree from Boston College Law School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-05-31 55,000 ( 0.05% ) 2 M $ 2026-05-30

Michael Marino active positions

CompaniesPositionStart
FRAZIER LIFESCIENCES ACQUISITION CORPORATION General Counsel 2025-04-30
Director/Board Member 2018-07-11

Former positions of Michael Marino

CompaniesPositionEnd
OPTINOSE, INC. General Counsel 2025-05-20
FIBROCELL SCIENCE, INC. General Counsel 2017-01-24
NUPATHE INC General Counsel 2014-02-28
Corporate Officer/Principal 2009-12-31
Corporate Officer/Principal -
See the detail of Michael Marino's experience

Training of Michael Marino

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Marino
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!